Should the Selective Arterial Secretagogue Injection Test for Insulinoma Localization Be Evaluated at 60 or 120 Seconds?-Reference-Cited by-同舟云学术

Should the Selective Arterial Secretagogue Injection Test for Insulinoma Localization Be Evaluated at 60 or 120 Seconds?

Published:2017 Issue:22 Volume:56 Page:2985-2991
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ueda Keijiro¹,Ito Tetsuhide¹,Kawabe Ken¹,Lee Lingaku²,Fujiyama Takashi¹,Tachibana Yuichi¹,Miki Masami¹,Yasunaga Kohei¹,Takaoka Takehiro¹,Nishie Akihiro³,Asayama Yoshiki³,T. Jensen Robert⁴,Ogawa Yoshihiro¹⁵

Affiliation:

1. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan

2. Department of Gastroenterology, Kyushu Rosai Hospital, Japan

3. Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Japan

4. Digestive Diseases Branch, National Institutes of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA

5. Department of Molecular Endocrinology and Metabolism, Graduate School of Medicine Tokyo Medical and Dental University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/22/56_9107-17/_pdf

Reference26 articles.

1. 1. Jensen RT, Cadiot G, Brandi ML, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: Functional pancreatic endocrine tumor syndromes. Neuroendocrinology 95: 98-111, 2012.

2. 2. Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50: 58-64, 2015.

3. 3. Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, et al. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE). Ann Oncol 21: 1794-1803, 2010.

4. 4. Ito T, Igarashi H, Jensen RT. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): Recent insights and advances. J Gastroenterol 47: 941-960, 2102.

5. 5. Nikfarjam M, Warshaw AL, Axelrod L, et al. Improved contemporary surgical management of insulinomas: A 25-year experience at the Massachusetts general hospital. Ann Surg 247: 165-172, 2008.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 膵NENの画像診断;Suizo;2023-12-28

2. The Management of Insulinoma;The Pancreas;2023-08-04

3. Intraoperative selective arterial calcium injection test to confirm complete resection of a proinsulinoma;Journal of Surgical Case Reports;2022-07-01

4. Selective Intra-Arterial Calcium Stimulation Venous Sampling Test for Preoperative Localization of Occult Neuroendocrine Tumors: Recall for an Old Technique;Digestive Disease Interventions;2021-02-11

5. Low-dose Selective Arterial Calcium Stimulation Test for Localizing Insulinoma: A Single-center Experience of Five Consecutive Cases;Internal Medicine;2020-10-01